Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.4500 (1.49%) ($5.4000 - $5.9200) on Thu. Jul. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.79% (three month average) | RSI | 44 | Latest Price | $5.4500(1.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(9%) LIT(8%) OIH(8%) IPO(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.395% in a week (0% probabilities). SHY(-18%) IBB(-9%) XBI(-8%) XLU(-6%) XLP(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.395% (StdDev 4.79%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
1 - 5 Day Possible Target | $-17.02(-412.29%) | Resistance Level | $6.02 | 5 Day Moving Average | $5.31(2.64%) | 10 Day Moving Average | $5.74(-5.05%) | 20 Day Moving Average | $6.02(-9.47%) | To recent high | -34.5% | To recent low | 7.1% | Market Cap | $47m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |